| 000 | 019950000a22003970004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223024831.0 | ||
| 008 | 061017s2006 ua a f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.15.M.Sc.2006.Ah.M. | ||
| 100 | 0 | _aAhmad Mohammad Taher Hashem | |
| 245 | 1 | 0 |
_aModern management of osteoporosis : _bSolutions and revolutions / _cAhmad Mohammad Taher Hashem ; supervised Shamel Mostafa Hefni , Hesham Omar Kandeel , Ibrahim Ahmad Shaaban |
| 246 | 1 | 5 | _aالعلاج الحديث لهشاشة العظام : الحلول و التطورات |
| 260 |
_aCairo : _bAhmad Mohammad Taher Hashem , _c2006 |
||
| 300 |
_a196P : _bill ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Gynecology and Obstetrics | ||
| 520 | _aPostmenopausal osteoporosis can be diagnosed by DXA (dual energy X - ray absorptiometry) or other measures as quantitative computed tomography and ultrasonographyThere are various measures of prevention and treatment of postmenopausal osteoporosis : 1Nonpharmacological Measures : as adequate calcium and vitamin D intake , and adequate exercise specially during puberty2 - Pharmacological Measures : as HRT (hormone replacement therapy) , Bisphopsphonates , SERMs (Selective Estrogen Receptor Modulators) , Calcitonin , Tibolone and Parathyroid Hormone | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBisphosphonates | |
| 653 | 4 | _aBone Mineral Density | |
| 653 | 4 | _aHormone Replacement Therapy | |
| 653 | 4 | _aMenopause | |
| 653 | 4 | _aOsteoporosis | |
| 653 | 4 | _aSelective estrogen Receptor Modulators | |
| 653 | 4 | _aSERMs | |
| 700 | 0 |
_aHesham Omar Kandeel , _esupervisor |
|
| 700 | 0 |
_aIbrahim Ahmad Shaaban , _esupervisor |
|
| 700 | 0 |
_aShamel Mostafa Hefni , _esupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aEnas _eCataloger |
||
| 905 |
_aMustafa _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c60 _d60 |
||